Clinical Trial Update: CelAgace™ OraRinse Solution for Treatment of Candidiasis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CelAgace OraRinse Solution in Phase 1/Phase 2 exploring treatment of oral candidiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis Oral

Drugs mentioned

• CelAgace OraRinse Solution

Snippet

Sponsor: CelaCare Technologies, Inc. | Conditions: Candidiasis, Oral | Phase 1, Phase 2 | Status: UNKNOWN